Incepto, the French Digital Health Specialist, is Raising €27 million to Support Its European Development
Founded in 2018, Incepto is a unique platform on the market that offers doctors and hospitals access to a portfolio of solutions based on artificial intelligence, designed to improve the quality of diagnoses, and save time for medical teams, without having to change equipment. In order to support its growth at a European scale, Incepto is raising €27 million today. The financing round is led by LBO France's Venture - Digital Health team, with the participation of Wille Finance and the historical investors AXA Venture Partners, the Patient Autonome fund of Bpifrance and Karista. This financing marks a new stage for Incepto, which is launching its offer in four new countries in Europe (Germany, Spain, Italy and Portugal).
As part of Incepto’s development, four new subsidiaries are created in Germany, Spain, Italy and Portugal with the aim of anchoring its position as European leader in the sector and treat one million European patients per month by 2024.
From a French start-up to a European scale-up
Incepto is also announcing the signing of five new partnerships (IB Lab, Milvue, PAIRE, SmartSoft and Thirona) to expand its portfolio of medical imaging applications for emergency care, oncology, orthopaedics, rheumatology and pneumology.
By extending its geographical coverage and developing its portfolio of applications, Incepto is responding to major public health issues: reducing waiting times for examinations, mitigating the lack of specialists for certain serious diseases and supporting doctors' work in the face of the increasing amount of data to be analysed.
In light with the explosion of the AI market in Europe, Incepto has three strategic objectives:
▪ Selecting and make available the most powerful AI solutions in medical imaging for each specialty, guaranteeing high quality standards;
▪ Creating, with doctors new applications that meet real needs but that do not exist yet: ARVA and KEROS are thus the first products co-developed by Incepto for the diagnostic assistance of aortic aneurysms in CT scanners and for MRI of the knee;
▪ Supporting the transformation of organisations and working methods by rethinking patient care with medical teams to exploit the full potential of artificial intelligence technologies.
About Incepto
Created in 2018, Incepto is the first European platform for artificial intelligence solutions applied to medical imaging. With a hundred clinics equipped with their AI solutions and already more than 100,000 patients monitored every month, Incepto's mission is twofold: to help doctors identify the most efficient solutions and put them at their service, while co-creating new applications with them, adapted to their specific needs. Incepto's ambition is to assist doctors on a daily basis in improving the accuracy of diagnoses, the treatment process and the quality of patient care.
https://incepto-medical.com/fr
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220919005036/en/
Contact information
Press Contact
Aude Vayre : 00 33 6 14 64 15 65 / aude.vayre@grayling.com
Anne Levasseur : 00 33 6 68 52 14 09 / anne.levasseur@citigatedewerogerson.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
PUMA Appoints Nadia Kokni as Vice President Global Brand Marketing8.1.2026 17:30:00 EET | Press release
Sports company PUMA has appointed Nadia Kokni as Vice President, Global Brand Marketing, effective January 1, 2026. Nadia joins PUMA’s global leadership team and reports directly to Chief Brand Officer Maria Valdes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108099913/en/ Sports company PUMA has appointed Nadia Kokni as Vice President, Global Brand Marketing, effective January 1, 2026. Nadia joins PUMA’s global leadership team and reports directly to Chief Brand Officer Maria Valdes. In her new role as PUMA’s most senior global marketing leader, Nadia will oversee brand marketing strategy, brand marketing creative direction, integrated marketing and communication globally. Her appointment comes as PUMA accelerates its global brand ambition and sharpens storytelling around its product icons and innovation pipeline. Nadia brings deep international experience shaping and transforming leading global brands across the spor
Xsolla Kicks Off Two Weeks of Industry Programming, Community Events, and Expanding Support for Global Developers Across the UK at the Industry’s Biggest Winter Event8.1.2026 17:00:00 EET | Press release
Xsolla, a global video game commerce company that helps developers launch, grow, and monetize their games, today announces a comprehensive program of events and activations across the United Kingdom taking place from January 10 to 22, 2026. This coordinated programming schedule reflects Xsolla’s continued investment in the UK and European games ecosystem. Capitalizing on a pivotal moment in the global games calendar, Xsolla is bringing developers, partners, and creators together through partnerships, live events, thought leadership, and community building. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108943976/en/ (Graphic: Xsolla) “Pocket Gamer Connects London brings together one of the most diverse and forward-thinking communities in the mobile global games industry,” said Berkley Egenes, Chief Marketing and Growth Officer. “We’re here to build all the things for the video game industry by helping developers turn grea
Golub Capital Continues Strong Track Record of Consistent Results in 20258.1.2026 17:00:00 EET | Press release
Golub Capital delivered another year of “good boring,” consistent results for its stakeholders in 2025, aided by its commitment to specialization. “We have long believed that specialization is a key source of competitive advantage for Golub Capital,” said David Golub, President of the Firm. “The past year validated this. Our deep relationships, scale and expertise enabled us to continue delivering strong results for investors, sponsors, portfolio companies and our team despite a muted M&A environment and high levels of credit stress across the private equity ecosystem. We are grateful for our clients’ trust and remain committed to building long-term, win-win partnerships that endure through market cycles.” 2025 Highlights, based on preliminary results:1 Delivering strong credit performance, record fundraising and continued leadership in sponsor finance Closed $25+ billion in financing commitments in 2025 to support existing portfolio companies and new platforms across a broad range of
AMRA Medical Introduces AMRA® BCP Scan in the Netherlands Through a Strategic Partnership with Prescan, a National Preventative Health Leader8.1.2026 16:31:00 EET | Press release
AMRA Medical, the global leader in MRI-based fat distribution and muscle composition analytics, alongside Dutch preventative healthcare leader Prescan, are pleased to announce the official launch of our cutting-edge AMRA® BCP Scan service, powered by AMRA® Profiler (CE, NB 2862), in the Netherlands. The launch, which marks BCP Scan’s third new market entry of 2025 (Sweden & Germany), expands the availability of our service within the EU into the Netherlands through an exclusive partnership with Prescan, an independent health & wellness clinic in Baarn which specializes in preventive health screenings and care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108381985/en/ AMRA® BCP Scan available at Prescan AMRA’s CEO, Olof Dahlqvist Leinhard, stated, “This is another important step in bringing our mission of driving scientific breakthroughs into the clinic by enabling deeper understanding of health and disease through MRI-
Andersen Expands Capabilities with Addition of Scimitar8.1.2026 16:30:00 EET | Press release
Andersen Consulting enters into a Collaboration Agreement with Scimitar, a firm focused on accelerating innovation in the life sciences industry. Headquartered in the U.S., Scimitar, a premier strategy execution consulting firm for the life sciences industry, specializes in operating model design, digital transformation, and organizational change. The firm works with pharmaceutical and biotech companies to accelerate innovation, improve operational execution, and ensure compliance across the product lifecycle. Their hands-on, collaborative approach ensures solutions are not only fit for purpose but built to scale. “Life sciences companies are navigating a period of rapid scientific advancement, growing regulatory complexity, and increasing demand for operational agility while being held to the highest standards of patient safety and data integrity,” said Ramy Khalil, CEO of Scimitar. “By combining our deep industry knowledge with Andersen’s global reach and multidisciplinary capabiliti
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
